A National Academy of Sciences (NAS) panel is recommending that health clinicians offer patients blood testing if they are likely to have elevated exposures to per- and polyfluoroalkyl substances (PFAS) due to work or community exposures and advises federal agencies to launch research into PFAS in breastmilk and formula. Such recommendations are expected to bolster efforts by plaintiffs in class action cases and other venues who are seeking to require PFAS manufacturers and users of the chemicals to compensate them...